Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02738840 · ClinicalTrials.gov registry record · NA
A Post-Market Study Evaluating the Prodigy MRI and Proclaim Elite MR Conditional SCS Systems
A NA study, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 56
- Enrollment target
NCT02738840 is a NA study that has completed, run by Abbott Medical Devices. The registered enrollment target is 56 participants.
The verdict
NCT02738840, a NA study, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 56 participants
- Enrollment target
Study Summary
A post market study evaluating the safety of the Prodigy MRI and Proclaim Elite MR conditional Spinal Cord Stimulator (SCS) systems.
Interventions
- PROCEDURE MRI scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2016-10-21 |
| Est. Completion | 2020-12-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02738840
The ClinicalTrials.gov registry entry for NCT02738840 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MRI scan is the first listed.
NCT02738840 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02738840 about?
NCT02738840 is a clinical study titled "A Post-Market Study Evaluating the Prodigy MRI and Proclaim Elite MR Conditional SCS Systems". A post market study evaluating the safety of the Prodigy MRI and Proclaim Elite MR conditional Spinal Cord Stimulator (SCS) systems.
What is the current status of trial NCT02738840?
This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2016-10-21. Estimated completion is 2020-12-02.
What interventions are being tested in trial NCT02738840?
The interventions under investigation include: MRI scan (PROCEDURE).
Who is sponsoring clinical trial NCT02738840?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.